Bristol-Myers Squibb Co (NYSE:BMY)

Delayed Data
As of Apr 24
 -0.20 / -0.30%
Today’s Change
Today|||52-Week Range
Benzinga's Weekend M&A Chatter
8:33pm / Benzinga
CAR-T Therapy Stocks Hit Hard Following AACR Data
Apr 20 / Benzinga
U.S. Tech, Dollar & Health Care ETFs To Watch This Week
12:19pm / Benzinga
Bristol-Myers combination melanoma treatment shows promise
Apr 20 /
Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs
Apr 25 /
Bristol-Myers Squibb Reports First Randomized Study Evaluating Opdivo+Yervoy Regimen ...
Apr 20 / Benzinga
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
Apr 24 /
Is Bristol-Myers Squibb. Co. About to Fall Apart?
Apr 20 /
Market Wrap: Record Close for S&P
Apr 24 /
Best Pure Play Investment in Cancer Drugs
Apr 19 /
Rigs Reduction
Apr 24 /
Bristol-Myers to Transfer Certain Erbitux Rights to Eli Lilly - Analyst Blog
Apr 17 /
AstraZeneca forced to defend cancer drug deal with Celgene
Apr 24 /
The Best Stock to Invest in Hep C
Apr 16 /
Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog
Apr 23 /
The Medicines Co.'s Kengreal Briefing Documents Positive - Analyst Blog
Apr 14 /
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
Apr 22 /
2 Speculative Biotechs That Could Be Well Worth the Risk
Apr 14 /
Roche boosted by US drugs sales
Apr 22 /
AstraZeneca's Onglyza Briefing Documents Raise Concern - Analyst Blog
Apr 13 /
Bristol-Myers Announces Positive Data from Opdivo Study - Analyst Blog
Apr 21 /
Biotech: Making sense of the science
Apr 13 /
Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog
Apr 21 /
Big pharma turns to small biotechs for edge in cancer treatment
Apr 07 /
Bristol-Myers Squibb Company (BMY) Highlighted As Momo Momentum Stock
Apr 21 /

To view my watchlist

Not a member yet?

Sign up now for a free account